| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.078 | 0.6 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |